CordenPharma provides customers with dedicated technologies for the production of Sterile Segregated Antibiotic APIs through our experience with aseptic technique.

Our sterile manufacturing facilities are comprised of:

  • >> Chemical Processing & Sterile Filtration
  • >> Crystallisation
  • >> Isolation
  • >> Drying & Powder Treatment
  • >> Blending with Sterile Excipients

Sterile cephalosporins, penicillins and monobactams are manufactured in dedicated manufacturing lines with up to 32,000 L total vessel capacity and 25,000 L total vessel capacity respectively.

Sterilization, blending and milling are all completed onsite.

Once the sterile API is obtained, material can be either supplied as sterile bulk or further processed into sterile powder-filled vials via our onsite aseptic filling operations (see Sterile Powder Fill) in an integrated supply offering.

Integrated Supply

CordenPharma’s ability to develop and manufacture Active Pharmaceutical Ingredients (APIs), Finished Dosage and Packaging in our network of facilities allows clients full access to integrated services resulting in a simplified supply chain, reduced risk and cost associated with technology transfers, and ultimately faster production and delivery timelines.

Related Facilities & Platforms

Technology Platforms